TY  - JOUR
AU  - Fernandez-Cuerva, Cristina
AU  - Del-Rio-Valencia, Juan Carlos 
AU  - Tamayo-Bermejo, Rocio 
PY  - 2022
DO  - 10.4212/cjhp.v75i1.3252
UR  - http://hdl.handle.net/10668/21629
T2  - The Canadian journal of hospital pharmacy
AB  - Real-world data are critical to demonstrate the reproducibility of evidence and the external generalizability of randomized clinical trials. Palbociclib is an oral small-molecule inhibitor of cyclin-dependent kinases 4/6 that has been shown to improve...
LA  - en
PB  - American Society for Microbiology
KW  - Cancer du sein métastatique
KW  - Cyclin-dependent kinase inhibitor
KW  - Fulvestrant
KW  - Inhibiteur des kinases dépendantes des cyclines
KW  - Letrozole
KW  - Létrozole
KW  - Metastatic breast cancer
KW  - Palbociclib
KW  - Breast Neoplasms
KW  - Fulvestrant
KW  - Duration of Therapy
KW  - Progression-Free Survival
KW  - Response Evaluation Criteria in Solid Tumors
TI  - Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results.
TY  - research article
VL  - 75
ER  -